Indian Journal of Dermatology
SHORT COMMUNICATION
Year
: 2013  |  Volume : 58  |  Issue : 5  |  Page : 352--354

Rebamipide: A novel agent in the treatment of recurrent aphthous ulcer and Behcet«SQ»s syndrome


Mohan H Kudur, Manjunath Hulmani 
 Department of Dermatology and Venereology, Srinivas Institute of Medical Sciences and Research Centre, Mukka, Surathkal, Mangalore, Karnataka, India

Correspondence Address:
Mohan H Kudur
Department of Dermatology and Venereology, Srinivas Institute of Medical Sciences and Research Centre, Mukka, Surathkalm, Mangalore, Karnataka
India

Rebamipide is an amino acid analog of 2 (1H)-quinolinone. It is being introduced and used since 1980 for the treatment of peptic ulcer. Its therapeutic use in recurrent aphthous ulcer was not known. It acts by the decrease in oxygen radicals, increase in blood flow and production of protective prostaglandins in ulcer mucosa, which accelerates the process of healing. In this article, we focus on the pharmacodynamics, pharmacokinetics, side-effects and other therapeutic uses of Rebamipide. It will be a new and effective drug in the dermatologists«SQ» drug armamentarium for the treatment of aphthous ulcers and related diseases.


How to cite this article:
Kudur MH, Hulmani M. Rebamipide: A novel agent in the treatment of recurrent aphthous ulcer and Behcet's syndrome.Indian J Dermatol 2013;58:352-354


How to cite this URL:
Kudur MH, Hulmani M. Rebamipide: A novel agent in the treatment of recurrent aphthous ulcer and Behcet's syndrome. Indian J Dermatol [serial online] 2013 [cited 2020 Aug 3 ];58:352-354
Available from: http://www.e-ijd.org/article.asp?issn=0019-5154;year=2013;volume=58;issue=5;spage=352;epage=354;aulast=Kudur;type=0